Extended Data Fig. 3: Sensitivity analysis of heat-related risks of non-fatal myocardial infarction (MI) at a maximum lag of 3 days stratified by medication intake in Augsburg, Germany, during the warm seasons from 2001 to 2014. | Nature Cardiovascular Research

Extended Data Fig. 3: Sensitivity analysis of heat-related risks of non-fatal myocardial infarction (MI) at a maximum lag of 3 days stratified by medication intake in Augsburg, Germany, during the warm seasons from 2001 to 2014.

From: Triggering of myocardial infarction by heat exposure is modified by medication intake

Extended Data Fig. 3: Sensitivity analysis of heat-related risks of non-fatal myocardial infarction (MI) at a maximum lag of 3 days stratified by medication intake in Augsburg, Germany, during the warm seasons from 2001 to 2014.The alternative text for this image may have been generated using AI.

(a) Effect modification by six medication types with more than 10% of intake frequency among the MI survivors (n = 2,124). The odds ratio (OR) is for the 95th percentile of temperature (95th; 24.2 °C) relative to the minimum MI risk temperature (MMIT; 7.5 °C). Data are presented as point estimates of OR ± 1.96 standard error (that is, 95% confidence intervals). Two-sided P-value (0.060 and 0.028 for antiplatelet and beta-receptor blockers intake, respectively; multiple comparisons were not adjusted) indicates the statistical significance of the difference in risk estimates between users and non-users of a specific medication, based on the z score calculated using the coefficients and standard errors for users and non-users. (b) Exposure-response curves for the temperature-MI relationship stratified by antiplatelet or beta-receptor blockers intake. Solid lines represent the point estimates of OR; shaded areas represent the 95% confidence intervals. Solid vertical lines are the minimum MI temperatures (MMIT; 7.5 °C) and dashed vertical lines are the 95th percentile of temperature (24.2 °C).

Source data

Back to article page